News & Press

News


Reversal of Cognitive Decline: 100 Patients

Dr. Dale Bredesen, along with colleagues from 15 different clinical sites, has just published a paper describing 100 patients with Alzheimer’s or pre-Alzheimer’s who had well documented, quantified improvements in cognition. More...

AHNP PRECISION HEALTH LAUNCHES THE RECODE REPORT

Partnering with Dr. Dale Bredesen, Alzheimer’s research pioneer and inventor of The Bredesen Protocol, AHNP Precision Health has launched the US version of the ReCODE Report, a proprietary implementation of the Bredesen Protocol which allows practitioners and individuals to achieve unprecedented success in the prevention and reversal of cognitive decline. Through genetics, blood biomarkers, and a multi-modal reporting system, patients and their physicians will receive new prevention and treatment options for early-stage Alzheimer’s disease. The report includes a detailed summary of the cause of the affected person’s symptoms and step-by-step suggestions to improve their cognition. More...

AHNP PRECISION HEALTH ACQUIRES MPI COGNITION DEMENTIA BUSINESS

AHNP Precision Health is announcing its acquisition of the MPI Cognition dementia business in order to rapidly bring a ground-breaking Alzheimer's treatment protocol designed by the leading Alzheimer's researcher to the market. Dale Bredesen MD, Founder, Co-Chairman, and Chief Science Officer of MPI Cognition is the best-selling author of the highly-acclaimed book, The End of Alzheimer’s. More...

Programs of Interest

Get In Touch

We would love to hear from you. Contact us with any questions or call us at 650.389.7633.

Terms of Service | Privacy Statement